retatrutide glucagon receptor The power of three: Retatrutide's role in modern obesity and diabetes therapy CAS 2381089-83-2 (Retatrutide) - BOC

The Lancet Diabetes & Endocrinology , 10(1), 45-57

NAION is sometimes described as an eye stroke because reduced blood flow damages the optic nerve, often causing painless blindness in one eye, loss of peripheral vision, blurred vision, or darkened visual fields that may not recover

They are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease or medical condition

Tirzepatide added GIP to that equation

In addition, a representative from the American Association of Clinical Endocrinology (AACE) (GEU) was appointed to the taskforce

However, while around 12% Americans use them and they are intended to be taken long-term, the majority stop taking them within a year